A Reno area referral page for the R3 Stem Cell network, which arranges cell therapy using donor birth tissue or the patient's own fat through affiliated local providers.
This listing is a Reno, Nevada page on the website of R3 Stem Cell, a network that describes itself as operating more than 80 centres in eight countries. It is important to understand what the page actually is: rather than describing a clinic in Reno, it invites the reader to telephone a central number so that the network can direct them to whichever affiliated provider is most convenient. No Reno clinic, no address and no local clinician is named.
The treatments described are those of the network rather than of any particular site. The page names three categories of stem cell: cells from the patient's own fat tissue, cells from umbilical cord tissue or cord blood, and cells from amniotic fluid. The first of those would be autologous, meaning taken from the patient, while the other two are donor-derived. Elsewhere on the network's site, platelet rich plasma (PRP, prepared from the patient's own blood), exosome treatment and a proprietary plasma preparation are also listed.
The network publishes detail on its donor material, stating that birth tissue is collected from healthy consenting women under the age of 35 at planned caesarean deliveries, using tissue that would otherwise be discarded. It claims these are Section 361 human tissue products under the federal regulations at 21 CFR Part 1271 and so do not require Food and Drug Administration licensing. Its own disclaimer states that stem cell therapy is experimental and not approved by that agency, and that is the statement a prospective patient should weigh.
Practically, a reader in Reno cannot establish from this page where they would be treated, by whom, or at what cost. Free consultations are offered and a toll-free number is given. Anyone considering this route should establish the name and licence of the treating clinician, the clinic's address, which specific product would be used and the total cost before committing, and should be cautious about the very wide range of conditions the network associates with treatment.
The page and the wider network site associate treatment with a broad range of conditions, most of which are not established indications for cell therapy.
The page names three categories of stem cell without saying which would be used for a given patient, and the choice between the patient's own tissue and donor birth tissue is left open.
No clinician is identified for Reno.
No premises are described. The page names no Reno clinic and publishes no street address, instead offering a location finder and a central toll-free number to connect the reader with an affiliated provider. There is no information about treatment rooms, accreditation, imaging guidance, or how and where donor tissue products are stored before use. For a reader trying to compare providers, this page functions as marketing for a network rather than as a description of a clinic, and essentially every practical detail would have to be obtained by telephone.
The page publishes no prices or price ranges. A free initial consultation is offered, at which costs would be discussed. Because the network's own disclaimer describes stem cell therapy as experimental and not approved by the Food and Drug Administration, treatment would be paid for privately rather than by insurance, so the total cost of a recommended course is the figure to ask for before travelling.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.